Delivery Order SPE2DR25D2006-SPE2DR26F57QL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,187.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price contract with an ultimate completion date of January 12, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a direct procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,566.00 firm fixed-price delivery order for Procainamide 1 gram/10 mL vials on November 24, 2025, with completion targeted for November 25, 2025. The award, which carries no set-aside designation, represents a competitively awarded delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,182.05 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on December 24, 2025, with an ultimate completion date of December 26, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,472.18 to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $7,465.68. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,791.77 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of December 18, 2025, and represents a non-competitive set-aside procurement. The award is performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Procainamide 1 gram/10 mL vials. This competitive, non-set-aside award carries a ceiling value of $3,145.00 and is scheduled for completion by August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57QLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,426.53 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 24, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside delivery order represents a critical pharmaceutical supply requirement for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. The company is a subsidiary of Cencora, Inc., which serves as the parent organization and prime vendor for pharmaceutical distribution across federal healthcare systems. This delivery order is executed under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. Through this contract vehicle, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the company's established capability to efficiently fulfill federal pharmaceutical procurement requirements on a competitive, full and open basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/23/26 |